Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta.
McDonald
W I
WI
Institute of Neurology, London, UK.
Miller
D H
DH
Thompson
A J
AJ
D002986:Clinical Trials as Topic / Q000379:methods*; D017326:Clinical Trials, Phase III as Topic / Q000379:methods; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy*; D011336:Probability; D012107:Research Design; D016896:Treatment Outcome
D016899:Interferon-beta